As of 9:30 AM on the 31st, Celltrion is trading at 302,500 KRW, down 0.66% from the previous day. This represents a 3.97% decrease compared to August 5. Celltrion is known as a protein and biopharmaceutical manufacturing company.

Over the past five days, individual investors have net purchased 17,170 shares, while foreigners and institutions have net purchased 73,139 shares and net sold 97,280 shares, respectively.


On August 26, Celltrion was a market topic due to the "approval of Phase 1 clinical trials for a COVID-19 treatment," which led to a strong performance.



※Source: AI Investment Assistant AI Lasso


※ This article was generated in real-time by an article automation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing